Gnrh Antagonists
GnRH Antagonist is a pharmacological agent that directly and competitively inhibits gonadotropin-releasing hormone receptors, thereby suppressing pituitary gonadotropin release and reducing ovarian steroidogenesis, particularly used in the medical management of uterine fibroids.
1.3K
Publications
59.6K
Citations
5.3K
Authors
1.3K
Institutions
Publications per year
2017–2026
207
Variants
Gonadotropin-releasing Hormone Antagonists
Parents
1.3K
Laurence Klotz, L Boccon-Gibod, Neal D. Shore et al. · British Journal of Urology · 2008 · 614 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 1.3K
5.3K
27
h-index
23
h-index
Neurocrine Biosciences (United States), United States
31 publications · 960 citations
20
h-index
Aristotle University of Thessaloniki, Greece
23 publications · 1.9K citations
20
h-index
18
h-index
1–5 of 5.3K
1.3K

Salk Institute for Biological Studies
La Jolla, United States
24 h-index
188 publications
7.8K citations
Neurocrine Biosciences (United States)
San Diego, United States
22 h-index
331 publications
10.7K citations

University of Lübeck
Lübeck, Germany
20 h-index
95 publications
7.6K citations
MRC Centre for Reproductive Health
Edinburgh, United Kingdom
19 h-index
53 publications
2.3K citations
National Institutes of Health
Bethesda, United States
19 h-index
73 publications
4.5K citations
Universitair Ziekenhuis Brussel
Brussels, Belgium
19 h-index
86 publications
4.4K citations
Aristotle University of Thessaloniki
Thessaloniki, Greece
19 h-index
41 publications
2.8K citations
University of California San Diego
San Diego, United States
18 h-index
63 publications
4.2K citations
1–8 of 1.3K
128 publications · 10.6K citations
63
h-index
JCEM · 84 publications · 6.2K citations
45
h-index
91 publications · 3.7K citations
39
h-index
58 publications · 3.7K citations
33
h-index
64 publications · 2.6K citations
31
h-index
1–5